Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYMBanks - Regional
+$0.15 today
- Market cap
- $12.16B
- Beta
- 0.76
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$2.54
Volume 5.80M
Average 4.76M
CHYM Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Chime Financial, Inc. Class A Common StockNASDAQ: CHYM
Operating Expenses · Q2 FY2026 · quarter ended Jun 2026
Operating expenses declines year over year
Q2 FY2026 operating expenses of $468.9M fell 66.3% year over year, behind the -21.3% change in trailing-twelve-month operating expenses. Sequentially, it fell 10.2% from the prior quarter. Over 3 fiscal years it compounded at +31.9% a year.
Context
- Operating expenses amounted to 133.4% of revenue in FY2025, up 42.1 pp from a year earlier.
- Operating expenses increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -66.3% toward the trailing-twelve-month pace of -21.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 2.92B USD
- Year-over-year change
- +91.0%
- 3-year CAGR
- +31.9%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.92B | +91.0% |
| FY2024 | 2024-12-31 | 1.53B | +18.0% |
| FY2023 | 2023-12-31 | 1.29B | +1.7% |
| FY2022 | 2022-12-31 | 1.27B | — |
Operating Expenses vs competitors
How CHYM compares with its peers on the latest reported figures
- Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -21.3% is the lowest of 7, against a peer median of +13.5%.
- Operating expenses amounts to 89.4% of revenue for CHYM, versus a peer median of 45.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | ¥218.23B JPY | -1.5% | -13.9% | 55.1% | |
| LTM Jun 2026 | $14.45B USD | +13.0% | +13.5% | 41.2% | |
| LTM Jun 2026 | $9.21B USD | -0.8% | -1.8% | 27.0% | |
| LTM Jun 2026 | $5.31B USD | +39.7% | +8.6% | 52.0% | |
| LTM Sep 2026 | $4.32B USD | +59.5% | +20.1% | 20.8% | |
| LTM Jun 2026 | $2.11B USD | -21.3% | +31.9% | 89.4% | |
| LTM Jun 2026 | $313.93M USD | +14.0% | -1.5% | 48.8% | |
| Peer median (excluding CHYM) | — | +13.5% | +3.5% | 45.0% | |
Competitors are the stored peer set for CHYM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 1.01B | 1.28B | 1.67B | 2.19B |
| Cost of Revenue | 214.69M | 219.74M | 207.51M | 309.03M |
| Gross Profit | 794.15M | 1.06B | 1.47B | 1.88B |
| Gross Margin | 78.7% | 82.8% | 87.6% | 85.9% |
| Research & Development | 242.43M | 259M | 309.58M | 934.93M |
| Selling, General & Admin | 603.94M | 598.75M | 696.99M | 1.15B |
| Operating Expenses | 1.27B | 1.29B | 1.53B | 2.92B |
| Depreciation & Amortization | 7.3M | 12.94M | 25.37M | 30M |
| EBITDA | (471.4M) | (222.85M) | (36.83M) | (979.11M) |
| EBITDA Margin | -46.7% | -17.4% | -2.2% | -44.8% |
| Operating Income | (478.7M) | (235.79M) | (62.2M) | (1.04B) |
| Operating Margin | -47.5% | -18.4% | -3.7% | -47.6% |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 8.11M | 32.82M | 39.47M | 30.87M |
| Income Before Tax | (470.59M) | (202.97M) | (22.73M) | (1.01B) |
| Pre-Tax Margin | -46.6% | -15.9% | -1.4% | -46.1% |
| Income Tax Expense | (337K) | 234K | 2.61M | 831K |
| Net Income | (470.25M) | (203.2M) | (25.34M) | (1.01B) |
| Net Margin | -46.6% | -15.9% | -1.5% | -46.2% |
| EPS (Basic) | (1.29) | (0.56) | (0.07) | (2.67) |
| EPS (Diluted) | (1.29) | (0.56) | (0.07) | (2.60) |
| Weighted Avg Shares | 364.42M | 364.42M | 364.42M | 378.75M |
| Weighted Avg Shares (Diluted) | 364.42M | 364.42M | 364.42M | 388.17M |
Chime Financial, Inc. Class A Common Stock
NASDAQ:CHYM
Intrinsic Alpha fair value
Locked
Current Price
$32.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.